Medicinova (MNOV) Exchange Rate Effect (2014 - 2025)
Medicinova (MNOV) posted quarterly Exchange Rate Effect of $16644.0 for Q4 2025, up 53.39% year-over-year from $10851.0 in Q4 2024, and up 83.49% quarter-over-quarter from $9071.0 in Q3 2025.
Medicinova (MNOV) Exchange Rate Effect (2014 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Exchange Rate Effect for 12 consecutive years, with $16644.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 53.39% year-over-year to $16644.0; the TTM figure through Dec 2025 stood at $15681.0 (up 296.29% YoY), while the FY2025 annual figure was $15681.0, up 296.29% from the prior year.
- Exchange Rate Effect improved to $16644.0 in Q4 2025 per MNOV's latest filing, from $9071.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $19096.0 in Q1 2021 and bottomed at -$25345.0 in Q3 2024.
- Historically, Exchange Rate Effect has averaged $2332.4 across 5 years, with a median of $3828.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 16013.33% in 2021 and fell as far as 9240.0% in 2021.
- Medicinova's Exchange Rate Effect stood at $5837.0 in 2021, then jumped by 76.19% to $10284.0 in 2022, then sank by 186.36% to -$8881.0 in 2023, then surged by 222.18% to $10851.0 in 2024, then soared by 53.39% to $16644.0 in 2025.
- Business Quant data shows MNOV's Exchange Rate Effect at $16644.0 in Q4 2025, $9071.0 in Q3 2025, and -$5423.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Medicinova | 68.66 Mn | 68.66 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,644.00 |
| Dec 31, 2025 | 16,644.00 |
| Sep 30, 2025 | 9,071.00 |
| Sep 30, 2025 | 9,071.00 |
| Jun 30, 2025 | -5,423.00 |
| Jun 30, 2025 | -5,423.00 |
| Mar 31, 2025 | -4,611.00 |
| Mar 31, 2025 | -4,611.00 |
| Dec 31, 2024 | 10,851.00 |
| Dec 31, 2024 | 10,851.00 |
| Sep 30, 2024 | -25,345.00 |
| Sep 30, 2024 | -25,345.00 |
| Jun 30, 2024 | 10,846.00 |
| Jun 30, 2024 | 10,846.00 |
| Mar 31, 2024 | 7,605.00 |
| Mar 31, 2024 | 7,605.00 |
| Dec 31, 2023 | -8,881.00 |
| Dec 31, 2023 | -8,881.00 |
| Sep 30, 2023 | 5,383.00 |
| Sep 30, 2023 | 5,383.00 |